Patents/Assignees

ENB Therapeutics, Inc.

2 patents in portfolio

US12533390utility2026
Methods and Compositions for Treatment of Endothelin B Receptor Expressing Tumors
0 cites
US12077604utility2024
Deuterated Compounds, Compositions, and Methods for Treating Cancers Associated with ETBR Activation
0 cites